| Rosacea

Epsolay vs Mirvaso

Side-by-side clinical, coverage, and cost comparison for rosacea.
Deep comparison between: Epsolay vs Mirvaso with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsMirvaso has a higher rate of injection site reactions vs Epsolay based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Mirvaso but not Epsolay, including UnitedHealthcare
Sign up to reveal the full AI analysis
Epsolay
Mirvaso
At A Glance
Topical
Once daily
Oxidizing agent
Topical
Once daily
Alpha-2 adrenergic agonist
Indications
  • Rosacea
  • Rosacea
Dosing
Rosacea Apply a pea-sized amount once daily in a thin layer to each area of the face (forehead, chin, nose, each cheek) on clean and dry skin; avoid eyes, lips, and mouth.
Rosacea Apply a pea-sized amount once daily to each of the five areas of the face (central forehead, chin, nose, each cheek) as a thin layer across the entire face, avoiding the eyes and lips; wash hands after applying.
Contraindications
  • History of hypersensitivity reactions to benzoyl peroxide or any components of the formulation
  • Hypersensitivity reaction to any component of MIRVASO topical gel (reactions have included angioedema, urticaria, and contact dermatitis)
Adverse Reactions
Most common (>=1%) Application site pain, erythema, pruritus, edema
Most common (>=1%) Erythema, flushing, skin burning sensation, contact dermatitis, dermatitis, skin warmth, paraesthesia, acne, skin pain, blurred vision, nasal congestion
Postmarketing Bradycardia, hypotension, angioedema, hypersensitivity, lip swelling, swollen tongue, throat tightness, urticaria, dizziness, pallor
Pharmacology
Benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic effects; the precise mechanism of action in the treatment of rosacea is unknown.
Brimonidine is a relatively selective alpha-2 adrenergic agonist; topical application of MIRVASO topical gel may reduce facial erythema through direct vasoconstriction.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Epsolay
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (0/12) · Qty limit (9/12)
View full coverage details ›
Mirvaso
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (5/12) · Qty limit (0/12)
View full coverage details ›
UnitedHealthcare
Epsolay
  • Covered on 4 commercial plans
  • PA (1/8) · Step Therapy (1/8) · Qty limit (0/8)
View full coverage details ›
Mirvaso
  • Covered on 4 commercial plans
  • PA (6/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Epsolay
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (2/3) · Qty limit (2/3)
View full coverage details ›
Mirvaso
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (1/3) · Qty limit (0/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Epsolay.
No savings programs available for Mirvaso.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
EpsolayView full Epsolay profile
MirvasoView full Mirvaso profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.